ExOlin + insulin aspart

ExOlin + insulin aspart is a **combination drug** consisting of ExOlin and insulin aspart. *Insulin aspart* is a rapid-acting recombinant insulin analogue used to control blood glucose in diabetes mellitus, acting by binding to the insulin receptor and activating cell signaling for glucose uptake and metabolism[5]. ExOlin is presumed to be a brand or proprietary formulation containing another insulin or insulin-related component combined with insulin aspart, but no specific details for ExOlin are available in the search results. The mechanism primarily involves mimicking physiological insulin spikes to improve glycemic control, with *insulin aspart* facilitating postprandial glucose uptake. This combination is likely used in the treatment of **type 1 and type 2 diabetes mellitus**, aiming to provide both basal and prandial glycemic coverage.

Brand names

ExOlin + insulin aspart

Other names

ExOlin + insulin aspart